Skip to main content

Table 13 The cost-effectiveness analysis in the 12-month intervention period (the incidence of diabetes)

From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

Group C (yuan) E (%) C/E ΔC/ΔE
The treatment group 21156020.3 16.5 1282183.0 −188775.1
The control group 18815209.0 28.9 651045.3